Cite
MLA Citation
Sergio Pagliarini et al.. “A 2-Year, Phase IV, Multicentre, Observational Study of Ranibizumab 0.5 mg in Patients with Neovascular Age-Related Macular Degeneration in Routine Clinical Practice: The EPICOHORT Study.” Journal of ophthalmology, vol. 2014, 2014, p. . http://access.bl.uk/ark:/81055/vdc_100082156610.0x00001f